Letter by Wu and Zhao Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"

被引：0
|
作者：
Wu, Kai [1 ]
Zhao, Song [1 ]
机构：
[1] Zhengzhou Univ, Dept Thorac Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源：
CIRCULATION | 2020年 / 142卷 / 01期
关键词：
D O I：
10.1161/CIRCULATIONAHA.119.045382
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E4
页数：2
相关论文
共 50 条
  • [1] Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF
    McMurray, John J., V
    Jackson, Alice M.
    Lam, Carolyn S. P.
    Redfield, Margaret M.
    Anand, Inder S.
    Ge, Junbo
    Lefkowitz, Marty P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Pfeffer, Marc A.
    Pieske, Burkert
    Rizkala, Adel R.
    Sabarwal, Shalini, V
    Shah, Amil M.
    Shah, Sanjiv J.
    Shi, Victor C.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Cikes, Maja
    Goncalvesova, Eva
    Katova, Tzvetana
    Kosztin, Anamaria
    Lelonek, Malgorzata
    Sweitzer, Nancy
    Vardeny, Orly
    Claggett, Brian
    Jhund, Pardeep S.
    Solomon, Scott D.
    [J]. CIRCULATION, 2020, 141 (05) : 338 - 351
  • [2] Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"
    Jackson, Alice M.
    Jhund, Pardeep S.
    Solomon, Scott D.
    McMurray, John J. V.
    [J]. CIRCULATION, 2020, 142 (01) : E5 - E6
  • [3] The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
    Gronda, Edoardo
    Vanoli, Emilio
    Iacoviello, Massimo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0L) : L77 - L81
  • [4] Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF
    Peikert, Alexander
    Vaduganathan, Muthiah
    Mc Causland, Finnian
    Claggett, Brian L.
    Chatur, Safia
    Packer, Milton
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin P.
    Pieske, Burkert
    Duengen, Hans-Dirk
    McMurray, John J. V.
    Solomon, Scott D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 794 - 803
  • [5] Duration of heart failure with preserved ejection fraction and treatment with sacubitril/valsartan: insights from the PARAGON-HF trial
    Ostrominski, John
    Claggett, B.
    Packer, M.
    Pfeffer, M.
    Lam, C.
    Zile, M.
    Desai, A.
    Jhund, P.
    Lefkowitz, M.
    Mcmurray, J.
    Solomon, S.
    Vaduganathan, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 119 - 119
  • [6] Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial
    Ostrominski, John W.
    Claggett, Brian L.
    Packer, Milton
    Pfeffer, Marc A.
    Lam, Carolyn S. P.
    Zile, Michael R.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Lefkowitz, Martin
    Mcmurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    [J]. JOURNAL OF CARDIAC FAILURE, 2023, 29 (11) : 1494 - 1503
  • [7] EFFECT OF SACUBITRIL/VALSARTAN ON SERUM LIPIDS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian
    Packer, Milton
    Zannad, Faiez
    Ananda, Inderjit
    Pieske, Burkert
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 556 - 556
  • [8] Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction:PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian L.
    Pfeffer, Marc A.
    Desai, Akshay S.
    Mc Causland, Finnian R.
    McGrath, Martina M.
    Anand, Inder S.
    van Veldhuisen, Dirk J.
    Kober, Lars
    Janssens, Stefan
    Cleland, John G. F.
    Pieske, Burkert
    Rouleau, Jean L.
    Zile, Michael R.
    Shi, Victor C.
    Lefkowitz, Martin P.
    McMurray, John J. V.
    Solomon, Scott D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2093 - 2101
  • [9] EFFECTS OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ON RENAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Peikert, Alexander
    Vaduganathan, Muthiah
    McCausland, Finnian
    Claggett, Brian
    Chatur, Safia
    Packer, Milton
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin
    Pieske, Burkert Mathias
    Dungen, Hans-Dirk
    McMurray, John J. V.
    Solomon, Scott D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 308 - 308
  • [10] Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial
    Lund, Lars H.
    Savarese, Gianluigi
    Venkateshvaran, Ashwin
    Benson, Lina
    Lundberg, Anna
    Donal, Erwan
    Daubert, Jean-Claude
    Oger, Emmanuel
    Linde, Cecilia
    Hage, Camilla
    [J]. ESC HEART FAILURE, 2022, 9 (01): : 164 - 177
12345